[Dynamic contrast-enhanced MRI for evaluating bone marrow microcirculation in malignant hematological diseases before and after thalidomide therapy].

The aim of the study was to measure microcirculation parameters by dynamic contrast-enhanced MRI (d-MRI) and to evaluate the anti-angiogentic effects during treatment with thalidomide in different hematologic malignancies.
In 20 healthy normal persons, 20 patients with myelodysplastic syndromes (MDS), 10 patients with multiple myeloma (MM) and 10 with myelofibrosis (MF) a fast gradient echo sequence (Turbo fast low angle shot 2D) with a pump controlled bolus infusion of gadolinium-DTPA was performed before and in 18 of these after beginning (average of 4.3 months) of a thalidomide therapy. Two pharmacokinetic parameters--the amplitude and exchange-rate-constant--were calculated and a statistical comparison of these values between healthy persons and patients as well as a correlation with the clinical course was executed.
Compared with the normal controls the patients showed a higher amplitude (normal persons 14.4 +/- 5.2, MDS 24.8 +/- 8.1, MF 35.9 +/- 4.3, MM 23.4 +/- 3.6) and exchange-rate-constant (normal persons 0.124 +/- 0.042, MDS 0.136 +/- 0.036, MF 0.144 +/- 0.068, MM 0.131 +/- 0.034). In the d-MRI-follow-up examinations a significant (p < 0.005) reduction of the amplitude and exchange rate constant values was evident in 14 of 18 patients undergoing a thalidomide therapy. Clinically all of these patients showed a therapy responding with complete or partial diseases remission.
In patients with hematologic malignancies significantly higher d-MRI-microcirculation parameters of the lumbar spine can be demonstrated than in normal persons. During anti-angiogenetic treatment with thalidomide a decrease of these values was observed in case of a responding to therapy.
AuthorsA Scherer, C Strupp, H J Wittsack, V Engelbrecht, R Willers, U Germing, N Gattermann, R Haas, U Mödder
JournalDer Radiologe (Radiologe) Vol. 42 Issue 3 Pg. 222-30 (Mar 2002) ISSN: 0033-832X [Print] Germany
Vernacular TitleDynamische kontrastverstärkte MRT zur Beurteilung der Knochenmarksmikrozirkulation bei malignen hämatologischen Erkrankungen vor und während einer Thalidomidtherapie.
PMID11963240 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Angiogenesis Inhibitors
  • Contrast Media
  • Thalidomide
  • Gadolinium DTPA
  • Adult
  • Aged
  • Angiogenesis Inhibitors (adverse effects, therapeutic use)
  • Bone Marrow (blood supply)
  • Contrast Media
  • Female
  • Gadolinium DTPA
  • Humans
  • Image Enhancement
  • Image Processing, Computer-Assisted
  • Lumbar Vertebrae (blood supply)
  • Magnetic Resonance Imaging
  • Male
  • Microcirculation (drug effects)
  • Middle Aged
  • Multiple Myeloma (diagnosis, drug therapy)
  • Myelodysplastic Syndromes (diagnosis, drug therapy)
  • Neovascularization, Pathologic (diagnosis, drug therapy)
  • Primary Myelofibrosis (diagnosis, drug therapy)
  • Thalidomide (adverse effects, therapeutic use)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: